跳至主要内容
临床试验/NCT02678416
NCT02678416已完成4 期

A Randomized, Placebo-Controlled, Double-Blind, Two-Part, Cross-over Study in Healthy Adult Male Subjects to Compare the Reduction in Pain Intensity After Single-Dose Administration of Intravenous or Oral Acetaminophen and Intravenous Morphine by Using UVB Burn and Intradermal Capsaicin Experimental Pain Models

Mallinckrodt1 个研究点 分布在 1 个国家目标入组 79 人开始时间: 2015年12月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Mallinckrodt
入组人数
79
试验地点
1
主要终点
Part 1: Change From Baseline in Pain Intensity at Hour 6 Using the Thermal Suprathreshold Pain in the Ultraviolet-B (UVB) Burn Pain Model

研究概览

简要总结

The purpose of this study is to evaluate two experimental pain models to see if they would be useful for comparing different products for reduction in pain intensity.

The models evaluated were the ultraviolet-B (UVB) burn and intradermal capsaicin experimental pain models. Medications compared were a single dose each, of intravenous (IV) acetaminophen, oral acetaminophen, placebo, and IV morphine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

IV Acetaminophen

Experimental

All participants receive IV acetaminophen as one of 4 interventions in random sequence

干预措施: IV Acetaminophen (Treatment A) (Drug)

IV Acetaminophen

Experimental

All participants receive IV acetaminophen as one of 4 interventions in random sequence

干预措施: Placebo (Treatment C) (Drug)

Oral Acetaminophen

Experimental

All participants receive oral acetaminophen as one of 4 interventions in random sequence

干预措施: Oral Acetaminophen (Treatment B) (Drug)

Oral Acetaminophen

Experimental

All participants receive oral acetaminophen as one of 4 interventions in random sequence

干预措施: Placebo (Treatment C) (Drug)

Placebo

Experimental

All participants receive placebo as one of 4 interventions in random sequence

干预措施: Placebo (Treatment C) (Drug)

Morphine

Experimental

All participants receive morphine as one of 4 interventions in random sequence

干预措施: Placebo (Treatment C) (Drug)

Morphine

Experimental

All participants receive morphine as one of 4 interventions in random sequence

干预措施: Morphine (Treatment D) (Other)

结局指标

主要结局

Part 1: Change From Baseline in Pain Intensity at Hour 6 Using the Thermal Suprathreshold Pain in the Ultraviolet-B (UVB) Burn Pain Model

时间窗: within 6 hours

The UVB burn pain model is a validated screening tool for pain killers in clinical drug development. A temperature of 50 degrees centigrade (°C) is used to burn the participant for 5 seconds. Then the participant rates his pain on a scale from 0 (no pain) to 10 (most intense pain). That score is recorded as baseline. Then the participant rates his pain again six hours after taking the assigned medication. The average at baseline is subtracted from the average at hour 6. Because this is a measure of reduction in pain intensity, a higher score is better (it means there is more pain relief).

次要结局

  • Part 2: Observed Thermal Suprathreshold Pain Intensity in the UVB Burn Area(within 6 hours)

研究者

发起方
Mallinckrodt
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验